Medicenna TherapeuticsCorp Financials
| MDNADelisted Stock | USD 0.31 0.00 0.00% |
With this module, you can analyze Medicenna financials for your investing period. You should be able to track the changes in Medicenna TherapeuticsCorp individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Medicenna |
Understanding current and past Medicenna TherapeuticsCorp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medicenna TherapeuticsCorp's financial statements are interrelated, with each one affecting the others. For example, an increase in Medicenna TherapeuticsCorp's assets may result in an increase in income on the income statement.
The data published in Medicenna TherapeuticsCorp's official financial statements usually reflect Medicenna TherapeuticsCorp's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medicenna TherapeuticsCorp. For example, before you start analyzing numbers published by Medicenna accountants, it's critical to develop an understanding of what Medicenna TherapeuticsCorp's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Medicenna TherapeuticsCorp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medicenna TherapeuticsCorp's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medicenna TherapeuticsCorp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicenna TherapeuticsCorp. Please utilize our Beneish M Score to check the likelihood of Medicenna TherapeuticsCorp's management manipulating its earnings.
Medicenna TherapeuticsCorp Stock Summary
Medicenna TherapeuticsCorp competes with Achilles Therapeutics, Checkpoint Therapeutics, Cue Biopharma, Pieris Pharmaceuticals, and Eliem Therapeutics. Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. Medicenna Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people.| Foreign Associate | Canada |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | CA58490H1073 |
| Business Address | 2 Bloor Street |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.medicenna.com |
| Phone | 416 648 5555 |
| Currency | USD - US Dollar |
You should never invest in Medicenna TherapeuticsCorp without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medicenna Stock, because this is throwing your money away. Analyzing the key information contained in Medicenna TherapeuticsCorp's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medicenna TherapeuticsCorp Key Financial Ratios
Generally speaking, Medicenna TherapeuticsCorp's financial ratios allow both analysts and investors to convert raw data from Medicenna TherapeuticsCorp's financial statements into concise, actionable information that can be used to evaluate the performance of Medicenna TherapeuticsCorp over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicenna TherapeuticsCorp reports annually and quarterly.Medicenna Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicenna TherapeuticsCorp's current stock value. Our valuation model uses many indicators to compare Medicenna TherapeuticsCorp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicenna TherapeuticsCorp competition to find correlations between indicators driving Medicenna TherapeuticsCorp's intrinsic value. More Info.Medicenna TherapeuticsCorp is regarded fifth in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medicenna TherapeuticsCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medicenna TherapeuticsCorp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicenna TherapeuticsCorp's earnings, one of the primary drivers of an investment's value.Medicenna TherapeuticsCorp Market Pulse
| Quote | 0.31 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 0.31 |
| Low | 0.3 |
| High | 0.31 |
| Volume | 0 |
| Exchange | NASDAQ |
About Medicenna TherapeuticsCorp Financials
What exactly are Medicenna TherapeuticsCorp Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Medicenna TherapeuticsCorp's income statement, its balance sheet, and the statement of cash flows. Potential Medicenna TherapeuticsCorp investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Medicenna TherapeuticsCorp investors may use each financial statement separately, they are all related. The changes in Medicenna TherapeuticsCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medicenna TherapeuticsCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Medicenna TherapeuticsCorp Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Medicenna TherapeuticsCorp is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Medicenna has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Medicenna TherapeuticsCorp's financials are consistent with your investment objective using the following steps:- Review Medicenna TherapeuticsCorp's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Medicenna TherapeuticsCorp's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Medicenna TherapeuticsCorp's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Medicenna TherapeuticsCorp's stock is overvalued or undervalued.
Medicenna TherapeuticsCorp April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medicenna TherapeuticsCorp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicenna TherapeuticsCorp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicenna TherapeuticsCorp based on widely used predictive technical indicators. In general, we focus on analyzing Medicenna Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicenna TherapeuticsCorp's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.26 | |||
| Information Ratio | 0.0356 | |||
| Maximum Drawdown | 60.35 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 12.82 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Medicenna Stock
If you are still planning to invest in Medicenna TherapeuticsCorp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medicenna TherapeuticsCorp's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |